3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
3
Pain
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Supratentorial Neoplasms
1
Pain, Intractable
1
Nephrolithiasis
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Leiomyoma
1
Kidney Neoplasms
1
Ileus
1
Chronic Pain
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Agnosia
1
Advanced Malignant Neoplasm
1
Interventions
Rituximab
7
Vemurafenib
4
Cyclophosphamide
4
Cladribine
4
Specimen Handling
3
Biopsy
3
obinutuzumab
2
ibrutinib
2
fludarabine phosphate
2
fludarabine
2
binimetinib
2
Diphenhydramine
2
Dexamethasone
2
Calcium Dobesilate
2
CT-P10
2
Acetaminophen
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
immunotoxin HA22
1
encorafenib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brexucabtagene autoleucel
1
auricularum
1
acalabrutinib
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Morphine
×
1 year
×
Clear all
No trials found.